A citation-based method for searching scientific literature

V Fonseca, A Schweizer, D Albrecht, M A Baron, I Chang, S Dejager. Diabetologia 2007
Times Cited: 289







List of co-cited articles
955 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes.
T Vilsbøll, J Rosenstock, H Yki-Järvinen, W T Cefalu, Y Chen, E Luo, B Musser, P J Andryuk, Y Ling, K D Kaufman,[...]. Diabetes Obes Metab 2010
235
57


Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus.
W Kothny, J Foley, P Kozlovski, Q Shao, B Gallwitz, V Lukashevich. Diabetes Obes Metab 2013
80
50

Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin.
Anthony H Barnett, Bernard Charbonnel, Mark Donovan, Douglas Fleming, Roland Chen. Curr Med Res Opin 2012
135
37

Effects of adding linagliptin to basal insulin regimen for inadequately controlled type 2 diabetes: a ≥52-week randomized, double-blind study.
Hannele Yki-Järvinen, Julio Rosenstock, Santiago Durán-Garcia, Sabine Pinnetti, Sudipta Bhattacharya, Sandra Thiemann, Sanjay Patel, Hans-Juergen Woerle. Diabetes Care 2013
104
32

Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin.
Emanuele Bosi, Riccardo Paolo Camisasca, Carole Collober, Erika Rochotte, Alan J Garber. Diabetes Care 2007
329
30

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
30

Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea.
A J Garber, J E Foley, M A Banerji, P Ebeling, S Gudbjörnsdottir, R-P Camisasca, A Couturier, M A Baron. Diabetes Obes Metab 2008
168
29

Efficacy and tolerability of vildagliptin monotherapy in drug-naïve patients with type 2 diabetes.
F Xavier Pi-Sunyer, Anja Schweizer, David Mills, Sylvie Dejager. Diabetes Res Clin Pract 2007
246
26

Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes.
Bo Ahrén, Anja Schweizer, Sylvie Dejager, Beth E Dunning, Peter M Nilsson, Margaretha Persson, James E Foley. J Clin Endocrinol Metab 2009
136
26


Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
24


Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.
Pablo Aschner, Mark S Kipnes, Jared K Lunceford, Matilde Sanchez, Carolyn Mickel, Debora E Williams-Herman. Diabetes Care 2006
634
22


Comparison between sitagliptin as add-on therapy to insulin and insulin dose-increase therapy in uncontrolled Korean type 2 diabetes: CSI study.
E S Hong, A R Khang, J W Yoon, S M Kang, S H Choi, K S Park, H C Jang, H Shin, G A Walford, S Lim. Diabetes Obes Metab 2012
63
34



Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.
John B Buse, Richard M Bergenstal, Leonard C Glass, Cory R Heilmann, Michelle S Lewis, Anita Y M Kwan, Byron J Hoogwerf, Julio Rosenstock. Ann Intern Med 2011
389
20

Efficacy and tolerability of vildagliptin in drug-naïve patients with type 2 diabetes and mild hyperglycaemia*.
W A Scherbaum, A Schweizer, A Mari, P M Nilsson, G Lalanne, S Jauffret, J E Foley. Diabetes Obes Metab 2008
96
20

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.
E Ferrannini, V Fonseca, B Zinman, D Matthews, B Ahrén, S Byiers, Q Shao, S Dejager. Diabetes Obes Metab 2009
212
20

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2012
20



Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy.
Anthony H Barnett, Bernard Charbonnel, Jia Li, Mark Donovan, Douglas Fleming, Nayyar Iqbal. Clin Drug Investig 2013
39
48

Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes.
Itamar Raz, Yu Chen, Mei Wu, Shehla Hussain, Keith D Kaufman, John M Amatruda, Ronald B Langdon, Peter P Stein, Maria Alba. Curr Med Res Opin 2008
181
18



Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus.
C Pan, X Xing, P Han, S Zheng, J Ma, J Liu, X Lv, J Lu, G Bader. Diabetes Obes Metab 2012
60
28

Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes.
J Rosenstock, C Aguilar-Salinas, E Klein, S Nepal, J List, R Chen. Curr Med Res Opin 2009
237
16

The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone.
Ralph A DeFronzo, Miguel N Hissa, Alan J Garber, Jorge Luiz Gross, Raina Yuyan Duan, Shoba Ravichandran, Roland S Chen. Diabetes Care 2009
324
16






Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.
M-R Taskinen, J Rosenstock, I Tamminen, R Kubiak, S Patel, K A Dugi, H-J Woerle. Diabetes Obes Metab 2011
246
15

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2015
15

Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial.
Julio Rosenstock, Michelle A Baron, Sylvie Dejager, David Mills, Anja Schweizer. Diabetes Care 2007
224
14


Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial.
Richard M Bergenstal, Carol Wysham, Leigh Macconell, Jaret Malloy, Brandon Walsh, Ping Yan, Ken Wilhelm, Jim Malone, Lisa E Porter. Lancet 2010
439
14

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.
Barry J Goldstein, Mark N Feinglos, Jared K Lunceford, Jeremy Johnson, Debora E Williams-Herman. Diabetes Care 2007
368
14

Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes.
J Rosenstock, S W Kim, M A Baron, R-P Camisasca, F Cressier, A Couturier, S Dejager. Diabetes Obes Metab 2007
200
14



Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1).
Matthew C Riddle, Thomas Forst, Ronnie Aronson, Leobardo Sauque-Reyna, Elisabeth Souhami, Louise Silvestre, Lin Ping, Julio Rosenstock. Diabetes Care 2013
200
14


A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Co-Administration of Sitagliptin with Intensively Titrated Insulin Glargine.
Chantal Mathieu, R Ravi Shankar, Daniel Lorber, Guillermo Umpierrez, Fan Wu, Lei Xu, Gregory T Golm, Melanie Latham, Keith D Kaufman, Samuel S Engel. Diabetes Ther 2015
31
45


2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial.
Baptist Gallwitz, Julio Rosenstock, Thomas Rauch, Sudipta Bhattacharya, Sanjay Patel, Maximilian von Eynatten, Klaus A Dugi, Hans-Juergen Woerle. Lancet 2012
254
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.